Business
Helix BioPharma Approved for NYSE Amex Listing
Helix BioPharma Approved for NYSE Amex Listing
About this update from Helix Biopharma Corp.
[{"type":"text","content":"\n\n\n\n Sep. 14, 2010 (Canada NewsWire Group) -- \n\n#ReleaseContent TABLE\n{\n BORDER-COLLAPSE: collapse\n}\nTR.cnwUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 1px solid\n}\nTR.cnwDoubleUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 3px double\n}\nTR.cnwBoldUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 3px solid\n}\nTD.cnwUnderlinedCell\n{\n BORDER-BOTTOM: #000000 1px solid\n}\nTD.cnwDoubleUnderlinedCell\n{\n BORDER-BOTTOM: #000000 3px double\n}\nTD.cnwBoldUnderlinedCell\n{\n BORDER-BOTTOM: #000000 3px solid\n}\n#ReleaseContent TABLE.cnwBorderedTable TD\n{\n BORDER-RIGHT: black 1px solid;\n PADDING-RIGHT: 2px;\n BORDER-TOP: black 1px solid;\n PADDING-LEFT: 2px;\n PADDING-BOTTOM: 2px;\n BORDER-LEFT: black 1px solid;\n PADDING-TOP: 2px;\n BORDER-BOTTOM: black 1px solid;\n BORDER-COLLAPSE: collapse\n}\n#ReleaseContent TABLE TD\n{\n PADDING-RIGHT: 2px;\n PADDING-LEFT: 2px;\n PADDING-BOTTOM: 2px;\n PADDING-TOP: 2px\n}\n\n\n >\n\nAURORA, Ontario, Sept. 14 /CNW/ -- Helix BioPharma Corp. (TSX, FSE: "HBP" / OTCQX: "HXBPF") today announced that it has been authorized to list its shares of common stock on the NYSE Amex stock exchange. The Company expects that shares of its common stock will begin trading on the NYSE Amex on September 15, 2010, under the trading symbol "HBP." The Company will delist from the OTCQX once trading begins on the NYSE Amex. The Company's listings on the Toronto and Frankfurt Stock Exchanges are unaffected by today's announcement.\n\n"We are very pleased to reach this significant milestone as part of Helix's development and future growth initiatives," Dr. Donald H. Segal, chairman of the board and chief executive officer, stated. "We believe that listing on the NYSE Amex stock exchange will prove to benefit our existing shareholders by helping to increase Helix's visibility, liquidity and suitability for a broader group of investors."\n\n"We are pleased to welcome Helix BioPharma Corp. to list its shares on NYSE Amex," said Scott Cutler, NYSE Euronext executive vice president. "We look forward to partnering with Helix BioPharma Corp. on NYSE Amex, the premier U.S. equities market for listing and trading small- and mid-cap growth companies, and to providing the highest levels of market quality to the company and its shareholders."\n\n >\n\nHeli...